Zilurgisertib fumarate is under clinical development by Incyte and currently in Phase II for Multiple Myeloma (Kahler Disease).

The Federal Trade Commission said three top pharmacy suppliers made profits of 7,700 percent on a lifesaving hypertension ...

Cycle Pharmaceuticals, Inc. (Cycle) announces today completion of the acquisition of Banner Life Sciences, LLC (Banner) which includes its BAFIERTAM ® (monomethyl fumarate) product for the treatment ...

A new study revealed safe MS treatment options during pregnancy, reassuring women to balance effective care with their plans ...

Discover outperforming stocks and invest smarter with Top Smart Score StocksFilter, analyze, and streamline your ...

CVS Caremark, Express Scripts and OptumRx dramatically mark up specialty generic drugs to affiliated pharmacies, the Federal ...

which includes its BAFIERTAM (monomethyl fumarate) product for the treatment of relapsing forms of multiple sclerosis (MS), in adults, approved by the US Food and Drug Administration (FDA). MS affects ...

The Federal Trade Commission voted unanimously to release additional findings from its yearslong probe into CVS Caremark, ...

The markups helped the PBMs reap $7.3 billion from 2017 to 2022, the FTC found. The PBMs—owned by insurers Cigna, CVS Health and UnitedHealth Group—are supposed to help keep drug costs low for ...

The largest pharmacy-benefit managers hiked the prices of certain drugs dispensed through their own pharmacies, according to ...

Every week, 4000 young women contract HIV. Discover hidden barriers to prevention and innovative solutions that can change ...

having started to feel the pinch with its current MS drugs like Tecfidera (dimethyl fumarate), Avonex (interferon beta-1a), and Tysabri (natalizumab). Tecfidera is being squeezed by cheaper ...